Crescent Biopharma, Inc.
CBIO
$12.58-2.56%
End of day · as of Oct 14, 2026, 8:00 PM ET
Mkt cap
$491.31M
EV/Sales
25.6
P/E ratio
N/A
FY2025 Revenue
$10.84M
EPS (FY2025)
N/A
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-1419.61%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Latest reported CBIO revenue for 2025-12-31 was $10.8M. Net income was -$153.9M. CBIO currently screens at market cap $491.3M.
Use this CBIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CBIO income, balance, and cash tables.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company in the Healthcare sector.
Latest cached Crescent Biopharma, Inc. (CBIO) revenue for Dec 31, 2025 was $10.8M. Net income was -$153.9M. Statements: https://lician.com/financials/cbio
Crescent Biopharma, Inc. (CBIO) market capitalization is $491.3M on the latest cached snapshot.
Crescent Biopharma, Inc. (CBIO) cached previous close $12.91; day range $12.54 – $12.67; volume 258,089. Session quote: https://lician.com/quote/cbio
Crescent Biopharma, Inc. (CBIO) latest cached earnings event is "CBIO earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CBIO filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/cbio